Randomized trial of ultraviolet irradiation units installed in homes of children and adolescents with asthma

Jonathan A. Bernstein MD , Anand Seth PhD , Marepalli Rao PhD , Janyce C. Katz JD , Umesh Singh MD, PhD , William Greisner MD , Michelle Lierl MD , Benjamin Prince MD , Kunjana Mavunda MD, MPH , Cheryl K. Bernstein RN, BS, CRCC , Tianyuan Guan PhD , Amy J. Nation DO , Amanda K. Rudman Spergel MD , Alkis Togias MD , Mark Glazman PhD
{"title":"Randomized trial of ultraviolet irradiation units installed in homes of children and adolescents with asthma","authors":"Jonathan A. Bernstein MD ,&nbsp;Anand Seth PhD ,&nbsp;Marepalli Rao PhD ,&nbsp;Janyce C. Katz JD ,&nbsp;Umesh Singh MD, PhD ,&nbsp;William Greisner MD ,&nbsp;Michelle Lierl MD ,&nbsp;Benjamin Prince MD ,&nbsp;Kunjana Mavunda MD, MPH ,&nbsp;Cheryl K. Bernstein RN, BS, CRCC ,&nbsp;Tianyuan Guan PhD ,&nbsp;Amy J. Nation DO ,&nbsp;Amanda K. Rudman Spergel MD ,&nbsp;Alkis Togias MD ,&nbsp;Mark Glazman PhD","doi":"10.1016/j.jacig.2025.100427","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Asthma management involves medications with environmental control, but patient adherence to the latter is poor. A previous pilot study found an ultraviolet indoor air-irradiation system (CREON2000A) was effective in reducing asthma severity in children with mild to moderate asthma.</div></div><div><h3>Objective</h3><div>This trial’s purpose was to confirm these results in a larger population over a longer time duration.</div></div><div><h3>Methods</h3><div>A 12-month randomized, sham device–controlled multicenter study enrolled 79 children with mild to moderate persistent asthma aged 6 to &lt;18 years. Participants were randomized to have a CREON2000A ultraviolet air irradiation device or a sham device installed in their home’s ventilation system. Enrolled children were assessed with the Composite Asthma Severity Index at baseline and every 4 months; asthma treatment was adjusted according to National Heart, Lung, and Blood Institute EPR-3 guidelines. The primary analysis compared the efficacy of the CREON2000A versus sham device from baseline to end of study (12-month visit). A sensitivity analysis compared efficacy across the 4-, 8-, and 12-month visits.</div></div><div><h3>Trial registration</h3><div>Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma (CREON2000A), <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span>, NCT02715375.</div></div><div><h3>Results</h3><div>Baseline demographic characteristics of CREON2000A (n = 40) versus sham device (n = 39) groups were similar. The primary analysis estimated a difference in Composite Asthma Severity Index score for CREON2000A at 12 months relative to the sham device, which was not statistically significant (Δ<sub>Estimated</sub> = 0.53; <em>P</em> = .404; 95% confidence interval, −0.576, 1.628). A sensitivity analysis detected a device benefit across all postbaseline values (Δ<sub>Estimated</sub> = 0.76; <em>P</em> = .034; 95% confidence interval, 0.057, 1.465). A benefit was also observed for asthma daytime symptom score, average asthma exacerbations score, missed school days, rhinitis symptoms, and average number of respiratory infections (nominal <em>P</em> &lt; .05 in all cases).</div></div><div><h3>Conclusion</h3><div>This small trial is inconclusive, but some results show promise, suggesting that this device and the concept of indoor air irradiation as an environmental intervention is worthy of further study in children with mild to moderate persistent asthma.</div></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"4 2","pages":"Article 100427"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772829325000281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Asthma management involves medications with environmental control, but patient adherence to the latter is poor. A previous pilot study found an ultraviolet indoor air-irradiation system (CREON2000A) was effective in reducing asthma severity in children with mild to moderate asthma.

Objective

This trial’s purpose was to confirm these results in a larger population over a longer time duration.

Methods

A 12-month randomized, sham device–controlled multicenter study enrolled 79 children with mild to moderate persistent asthma aged 6 to <18 years. Participants were randomized to have a CREON2000A ultraviolet air irradiation device or a sham device installed in their home’s ventilation system. Enrolled children were assessed with the Composite Asthma Severity Index at baseline and every 4 months; asthma treatment was adjusted according to National Heart, Lung, and Blood Institute EPR-3 guidelines. The primary analysis compared the efficacy of the CREON2000A versus sham device from baseline to end of study (12-month visit). A sensitivity analysis compared efficacy across the 4-, 8-, and 12-month visits.

Trial registration

Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma (CREON2000A), ClinicalTrials.gov, NCT02715375.

Results

Baseline demographic characteristics of CREON2000A (n = 40) versus sham device (n = 39) groups were similar. The primary analysis estimated a difference in Composite Asthma Severity Index score for CREON2000A at 12 months relative to the sham device, which was not statistically significant (ΔEstimated = 0.53; P = .404; 95% confidence interval, −0.576, 1.628). A sensitivity analysis detected a device benefit across all postbaseline values (ΔEstimated = 0.76; P = .034; 95% confidence interval, 0.057, 1.465). A benefit was also observed for asthma daytime symptom score, average asthma exacerbations score, missed school days, rhinitis symptoms, and average number of respiratory infections (nominal P < .05 in all cases).

Conclusion

This small trial is inconclusive, but some results show promise, suggesting that this device and the concept of indoor air irradiation as an environmental intervention is worthy of further study in children with mild to moderate persistent asthma.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
The journal of allergy and clinical immunology. Global
The journal of allergy and clinical immunology. Global Immunology, Allergology and Rheumatology
CiteScore
0.70
自引率
0.00%
发文量
0
审稿时长
92 days
期刊最新文献
Comparing approaches to ordering peanut component–resolved diagnostics to reduce the need for oral food challenges PI3K pathway activation in severe asthma is linked to steroid insensitivity and adverse outcomes Oral microbiota related to allergy in Norwegian adults Eosinophilic granulomatosis with polyangiitis: Patient profiles from a large US allergy practice Outcomes of drug provocation tests in children with chronic complications and comorbidities: Case series
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1